关于可卡因使用障碍患者心血管健康生理指标和生物标志物的单盲、随机对照应急管理试验

IF 3.9 2区 医学 Q1 PSYCHIATRY
William W. Stoops , Thomas P. Shellenberg , Sean D. Regnier , David H. Cox , Reuben Adatorwovor , Lon R. Hays , Danielle M. Anderson , Joshua A. Lile , Joy M. Schmitz , Jennifer R. Havens , Travis R. Sexton , Mary B. Fisher
{"title":"关于可卡因使用障碍患者心血管健康生理指标和生物标志物的单盲、随机对照应急管理试验","authors":"William W. Stoops ,&nbsp;Thomas P. Shellenberg ,&nbsp;Sean D. Regnier ,&nbsp;David H. Cox ,&nbsp;Reuben Adatorwovor ,&nbsp;Lon R. Hays ,&nbsp;Danielle M. Anderson ,&nbsp;Joshua A. Lile ,&nbsp;Joy M. Schmitz ,&nbsp;Jennifer R. Havens ,&nbsp;Travis R. Sexton ,&nbsp;Mary B. Fisher","doi":"10.1016/j.drugalcdep.2025.112642","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Limited prospective research has evaluated the health benefits associated with changing levels of drug use, aside from complete abstinence. This study determined whether lower levels of cocaine use impacted physiological indices (e.g., mean arterial pressure) and biomarkers (e.g., stromal cell derived factor-1a [SDF-1a], soluble intercellular adhesion molecule-1 [ICAM-1], neutrophil activating peptide-2 [CXCL7]) of cardiovascular health.</div></div><div><h3>Methods</h3><div>Treatment seeking participants enrolled in a 12-week single-blind, randomized, controlled cocaine contingency management trial. Participants were randomly assigned to High Value Reinforcers for cocaine abstinence (n = 41), Low Value Reinforcers for cocaine abstinence (n = 33) or a non-contingent Control group (n = 33). Physiological indices were collected at each clinic visit and averaged over each week of treatment. Biomarkers were assayed at 6-week intervals. Percent benzoylecgonine negative urines matching measurement timeframes were used to predict changes in outcomes using generalized linear models.</div></div><div><h3>Results</h3><div>Reductions in mean arterial pressure were observed in the High Value group, particularly during follow-up (<span><math><msubsup><mrow><mi>χ</mi></mrow><mrow><mo>(</mo><mn>1,107</mn><mo>)</mo></mrow><mrow><mn>2</mn></mrow></msubsup></math></span>= 6.6, p &lt; .05). Regardless of group, less cocaine use was associated with decreased SDF-1a and increased ICAM-1 and CXCL7 levels (all <span><math><msubsup><mrow><mi>χ</mi></mrow><mrow><mo>(</mo><mn>1,107</mn><mo>)</mo></mrow><mrow><mn>2</mn></mrow></msubsup></math></span>&gt; 4.7; p values &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>Improved blood pressure was observed in the High Value treatment group, who provided the greatest percent of cocaine negative urine samples but did not achieve total abstinence. Less cocaine use was also associated with changes in cardiac biomarkers that may indicate tissue repair. These results indicate that less cocaine use, even without complete abstinence, can improve blood pressure, and potentially heal cardiovascular insult, in individuals with Cocaine Use Disorder.</div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"271 ","pages":"Article 112642"},"PeriodicalIF":3.9000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A single-blind, randomized, controlled contingency management trial on physiological indices and biomarkers of cardiovascular health in people with cocaine use disorder\",\"authors\":\"William W. Stoops ,&nbsp;Thomas P. Shellenberg ,&nbsp;Sean D. Regnier ,&nbsp;David H. Cox ,&nbsp;Reuben Adatorwovor ,&nbsp;Lon R. Hays ,&nbsp;Danielle M. Anderson ,&nbsp;Joshua A. Lile ,&nbsp;Joy M. Schmitz ,&nbsp;Jennifer R. Havens ,&nbsp;Travis R. Sexton ,&nbsp;Mary B. Fisher\",\"doi\":\"10.1016/j.drugalcdep.2025.112642\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Limited prospective research has evaluated the health benefits associated with changing levels of drug use, aside from complete abstinence. This study determined whether lower levels of cocaine use impacted physiological indices (e.g., mean arterial pressure) and biomarkers (e.g., stromal cell derived factor-1a [SDF-1a], soluble intercellular adhesion molecule-1 [ICAM-1], neutrophil activating peptide-2 [CXCL7]) of cardiovascular health.</div></div><div><h3>Methods</h3><div>Treatment seeking participants enrolled in a 12-week single-blind, randomized, controlled cocaine contingency management trial. Participants were randomly assigned to High Value Reinforcers for cocaine abstinence (n = 41), Low Value Reinforcers for cocaine abstinence (n = 33) or a non-contingent Control group (n = 33). Physiological indices were collected at each clinic visit and averaged over each week of treatment. Biomarkers were assayed at 6-week intervals. Percent benzoylecgonine negative urines matching measurement timeframes were used to predict changes in outcomes using generalized linear models.</div></div><div><h3>Results</h3><div>Reductions in mean arterial pressure were observed in the High Value group, particularly during follow-up (<span><math><msubsup><mrow><mi>χ</mi></mrow><mrow><mo>(</mo><mn>1,107</mn><mo>)</mo></mrow><mrow><mn>2</mn></mrow></msubsup></math></span>= 6.6, p &lt; .05). Regardless of group, less cocaine use was associated with decreased SDF-1a and increased ICAM-1 and CXCL7 levels (all <span><math><msubsup><mrow><mi>χ</mi></mrow><mrow><mo>(</mo><mn>1,107</mn><mo>)</mo></mrow><mrow><mn>2</mn></mrow></msubsup></math></span>&gt; 4.7; p values &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>Improved blood pressure was observed in the High Value treatment group, who provided the greatest percent of cocaine negative urine samples but did not achieve total abstinence. Less cocaine use was also associated with changes in cardiac biomarkers that may indicate tissue repair. These results indicate that less cocaine use, even without complete abstinence, can improve blood pressure, and potentially heal cardiovascular insult, in individuals with Cocaine Use Disorder.</div></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"271 \",\"pages\":\"Article 112642\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S037687162500095X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S037687162500095X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

有限的前瞻性研究已经评估了与改变药物使用水平相关的健康益处,除了完全戒断。本研究确定较低水平的可卡因使用是否会影响心血管健康的生理指标(如平均动脉压)和生物标志物(如基质细胞衍生因子-1a [SDF-1a]、可溶性细胞间粘附分子-1 [ICAM-1]、中性粒细胞激活肽-2 [CXCL7])。方法寻求治疗的参与者参加了一项为期12周的单盲、随机、对照可卡因应急管理试验。参与者被随机分配到高价值强化组(n = 41),低价值强化组(n = 33)或非偶然对照组(n = 33)。在每次就诊时收集生理指标,并在治疗周内取平均值。每隔6周检测一次生物标志物。使用广义线性模型预测与测量时间框架相匹配的苯甲酰茶碱阴性尿液百分比的变化。结果高值组平均动脉压下降,特别是随访期间(χ(1107)2= 6.6, p < 0.05)。无论在哪个组,较少的可卡因使用与SDF-1a降低和ICAM-1和CXCL7水平升高相关(所有χ(1,107)2> 4.7;P值<; 0.05)。结论高值治疗组血压有所改善,尿样呈可卡因阴性比例最高,但未达到完全戒断。较少的可卡因使用也与心脏生物标志物的变化有关,这可能表明组织修复。这些结果表明,即使没有完全戒断,减少可卡因的使用也可以改善可卡因使用障碍患者的血压,并有可能治愈心血管损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A single-blind, randomized, controlled contingency management trial on physiological indices and biomarkers of cardiovascular health in people with cocaine use disorder

Introduction

Limited prospective research has evaluated the health benefits associated with changing levels of drug use, aside from complete abstinence. This study determined whether lower levels of cocaine use impacted physiological indices (e.g., mean arterial pressure) and biomarkers (e.g., stromal cell derived factor-1a [SDF-1a], soluble intercellular adhesion molecule-1 [ICAM-1], neutrophil activating peptide-2 [CXCL7]) of cardiovascular health.

Methods

Treatment seeking participants enrolled in a 12-week single-blind, randomized, controlled cocaine contingency management trial. Participants were randomly assigned to High Value Reinforcers for cocaine abstinence (n = 41), Low Value Reinforcers for cocaine abstinence (n = 33) or a non-contingent Control group (n = 33). Physiological indices were collected at each clinic visit and averaged over each week of treatment. Biomarkers were assayed at 6-week intervals. Percent benzoylecgonine negative urines matching measurement timeframes were used to predict changes in outcomes using generalized linear models.

Results

Reductions in mean arterial pressure were observed in the High Value group, particularly during follow-up (χ(1,107)2= 6.6, p < .05). Regardless of group, less cocaine use was associated with decreased SDF-1a and increased ICAM-1 and CXCL7 levels (all χ(1,107)2> 4.7; p values < 0.05).

Conclusions

Improved blood pressure was observed in the High Value treatment group, who provided the greatest percent of cocaine negative urine samples but did not achieve total abstinence. Less cocaine use was also associated with changes in cardiac biomarkers that may indicate tissue repair. These results indicate that less cocaine use, even without complete abstinence, can improve blood pressure, and potentially heal cardiovascular insult, in individuals with Cocaine Use Disorder.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug and alcohol dependence
Drug and alcohol dependence 医学-精神病学
CiteScore
7.40
自引率
7.10%
发文量
409
审稿时长
41 days
期刊介绍: Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信